Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company Otodyne Inc.
DescriptionIntranasal surfactant combined with an atni-inflammatory
Molecular Target
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPreclinical
Standard IndicationOtitis media
Indication DetailsTreat otitis media
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today